Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 3/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9298567 | 0.90 | SLC1A2 (0.33) | NR1H2NR1H3SLC1A2SLC1A1HSD11B1 | |
| SCHEMBL6916576 | 0.87 | MAPT (0.41) | SLC1A2SLC1A1HSD11B1MAPTPOLB | |
| SCHEMBL30142941 | 0.83 | SLC1A2 (0.36) | SLC1A2SLC1A1HSD11B1LMNA | |
| SCHEMBL27208664 | 0.83 | F10 (0.41) | MAPTLMNA | |
| SCHEMBL28949432 | 0.83 | SLC1A2 (0.36) | SLC1A2SLC1A1HSD11B1LMNA | |
| SCHEMBL19296162 | 0.82 | SLC1A2 (0.39) | SLC1A2SLC1A1HSD11B1POLBLMNA | |
| SCHEMBL158905 | 0.82 | SLC1A2 (0.39) | SLC1A2SLC1A1HSD11B1POLBLMNA | |
| SCHEMBL28968457 | 0.81 | SLC1A2 (0.38) | SLC1A2SLC1A1HSD11B1POLBLMNA | |
| SCHEMBL28968468 | 0.81 | SLC1A2 (0.38) | SLC1A2SLC1A1HSD11B1POLBLMNA | |
| SCHEMBL28968495 | 0.81 | SLC1A2 (0.38) | SLC1A2SLC1A1HSD11B1POLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023234201-A1 | LIQUID RESIN COMPOSITION AND RESIN-ENCAPSULATED POWER MODULE | 住友ベークライト株式会社 | 2023-12-07 | — | — | WO | claimed |
| CN-112795140-B | Epoxy resin coil for transformer and processing technology thereof | 中变集团上海变压器有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-112795140-A | Epoxy resin coil for transformer and processing technology thereof | 中变集团上海变压器有限公司 | 2021-05-14 | — | — | CN | claimed |
| EP-2588506-A1 | SELF LIMITING CATALYST COMPOSITION FOR ETHYLENE POLYMERIZATION | Dow Global Technologies LLC (US) | 2013-05-08 | — | — | EP | claimed |
| WO-2012003219-A1 | SELF LIMITING CATALYST COMPOSITION FOR ETHYLENE POLYMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-01-05 | — | — | WO | claimed |
| US-6380322-B1 | CROSSLINKED BLEND | GEORGIA TECH RESEARCH CORPORATION | 2002-04-30 | — | — | US | claimed |
| EP-0307665-B1 | Encapsulation composition and use thereof | IBM (US) | 1994-03-23 | — | — | EP | claimed |
| EP-0307665-A2 | Encapsulation composition and use thereof | International Business Machines Corporation (US) | 1989-03-22 | — | — | EP | claimed |
| WO-2024203772-A1 | METHOD FOR PRODUCING ALPHA-CYANOACRYLATE | 東亞合成株式会社 | 2024-10-03 | — | — | WO | disclosed |
| WO-2023234201-A1 | LIQUID RESIN COMPOSITION AND RESIN-ENCAPSULATED POWER MODULE | 住友ベークライト株式会社 | 2023-12-07 | — | — | WO | disclosed |
| CN-112795140-B | Epoxy resin coil for transformer and processing technology thereof | 中变集团上海变压器有限公司 | 2021-10-01 | — | — | CN | disclosed |
| CN-112795140-A | Epoxy resin coil for transformer and processing technology thereof | 中变集团上海变压器有限公司 | 2021-05-14 | — | — | CN | disclosed |
| US-20160168315-A1 | MODIFIED OLIGOESTERS AND MANUFACTURE METHODS OF THE OLIGOESTERS | ANHIDRIDOS Y DERIVADOS DE COLOMBIA S.A. ANDERCOL (CO) | 2016-06-16 | — | — | US | disclosed |
| WO-2014152543-A2 | OXETANE-CONTAINING COMPOUNDS AND COMPOSITIONS THEREOF | Henkel IP & Holding GmbH (DE) | 2014-09-25 | — | — | WO | disclosed |
| US-5068062-A | Crosslinked resin containing 4,4*-diaminodiphenylmethane units with the amine quaternized and an electrolytic material | TEIJIN LIMITED (JP) | 1991-11-26 | — | — | US | disclosed |
| EP-0446666-A2 | Solder interconnection structure on organic substrates and process for making | International Business Machines Corporation (US) | 1991-09-18 | — | — | EP | disclosed |
| EP-0446580-A1 | Solder interconnection structure with encapsulant and composition of the latter | International Business Machines Corporation (US) | 1991-09-18 | — | — | EP | disclosed |
| US-4999699-A | Solder interconnection structure and process for making | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1991-03-12 | — | — | US | disclosed |
| EP-0336391-A2 | Reversibly color-changeable materials | TEIJIN LIMITED (JP) | 1989-10-11 | — | — | EP | disclosed |
| EP-0307665-A2 | Encapsulation composition and use thereof | International Business Machines Corporation (US) | 1989-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168315-A1 | MODIFIED OLIGOESTERS AND MANUFACTURE METHODS OF THE OLIGOESTERS | OSTC, OSGEP, PUF60 | NR1H2 2069/4885NR1H3 1205/4885SLC1A2 4626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.